Evidence map›Paper›PMID 36322473›Full record

ArticleDrug development research2022

A cytotoxic survey on 2-amino-1H-imidazol based synthetic marine sponge alkaloid analogues.

Nikolett Gémes, Zsófia Makra, Patrícia Neuperger, Enikő Szabó, József Á Balog, Lili Borbála Flink, Beáta Kari, László Hackler, László G Puskás, Iván Kanizsai and 1 more

Abstract read
In one paragraph

Article in Drug development research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. The current landscape of indole hybrids withFuture medicinal chemistry · 2025
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nikolett GémesLaboratory of Functional Genomics, Biological Research Centre, Szeged, Hungary.
Zsófia MakraAvidin Ltd, Szeged, Hungary.
Patrícia NeupergerLaboratory of Functional Genomics, Biological Research Centre, Szeged, Hungary.
Enikő SzabóLaboratory of Functional Genomics, Biological Research Centre, Szeged, Hungary.
József Á BalogLaboratory of Functional Genomics, Biological Research Centre, Szeged, Hungary.
Lili Borbála FlinkDepartment of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
Beáta KariAvidin Ltd, Szeged, Hungary.
László HacklerAvidin Ltd, Szeged, Hungary.
László G PuskásLaboratory of Functional Genomics, Biological Research Centre, Szeged, Hungary.
Iván KanizsaiAvidin Ltd, Szeged, Hungary.ORCID 0000-0003-0109-7097
Gábor J SzebeniLaboratory of Functional Genomics, Biological Research Centre, Szeged, Hungary.ORCID 0000-0002-6998-5632

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we describe the synthesis and biologic activity evaluation of 20 novel synthetic marine sponge alkaloid analogues with 2-amino-1H-imidazol (2-AI) core. Cytotoxicity was tested on murine 4T1 breast cancer, A549 human lung cancer, and HL-60 human myeloid leukemia cells by the resazurin assay. A total of 18 of 20 compounds showed cytotoxic effect on the cancer cell lines with different potential. Viability of healthy human fibroblasts and peripheral blood mononuclear cells upon treatment was less hampered compared to cancer cell lines supporting tumor cell specific cytotoxicity of our compounds. The most cytotoxic compounds resulted the following IC

Indexed as

Antineoplastic AgentsPoriferaAnimalsApoptosisCell Line, TumorCell ProliferationHumansLeukocytes, MononuclearMiceAntineoplastic Agents2-amino-(1H)-imidazole4T1 breast cancerA549 lung cancerHL-60 myeloid leukemiaMannich

Identifiers

PMID36322473
PMCPMC10091778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.